Good spotto thanks Thurton. I frankly had not been aware of the following and has wondered where the rationale for trialling on MND had come from. Assume my bad !
This statement brings a new slant to the whole subject from my perspective.
"Pre-clinical studies have shown that monepantel can slow disease progression in MND"
Frankly does not have to achieve astoundingly successful outcomes to be taken pretty seriously for this insidious malaise. Lets hope it can bring relief for any and all sufferers.
PharmAust ready to trial monepantel on humans to fight motor neurone disease, page-8
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |